Find and Pitch Jounalists, Get Your Story Covered

Tags: cancer metformin myeloid leukemia burn scars marjolin's ulcer

	Profile	Recent Articles on Subject
1	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Older Men Increasingly Overtreated for Prostate Cancer, Study Suggests - 7 days ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 2 months ago HIFU Non-Inferior to Prostatectomy for Localized Prostate Cancer - 7 months ago Francis Collins Discloses His 'Aggressive' Prostate Cancer Diagnosis - 7 months ago PSA and Biomarker Testing Plus MRI Appears to Improve Prostate Cancer Screening - 8 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - 10 months ago Olaparib-Abiraterone in Biomarker-Selected mCRPC Tops Each Agent Alone - 10 months ago Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC - 10 months ago FDA Approves Belzutifan for Advanced Renal Cell Carcinoma - 11 months ago TULSA Effective in Controlling Prostate Cancer Long-Term - 12 months ago First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response - 12 months ago Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer - 12 months ago Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer - 12 months ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - about 1 year ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	MHRA grants approval for bladder cancer drug erdafitinib - 12 days ago ERLEADA shows 23% survival benefit over enzalutamide in prostate cancer study - about 2 months ago
3	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Sequencing in Advanced Urothelial Carcinoma - 17 days ago Study Tests Office-Based Transperineal Approach to Prostate Biopsies - 9 months ago Cabozantinib Plus Atezolizumab Improves PFS in Metastatic CRPC - 9 months ago Novel Prostate Cancer Screening Method Could Prevent Unnecessary Biopsies - 9 months ago KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - 11 months ago
4	Andrew Joseph STAT News Reporter at STAT. Covers health, medicine in Europe. London, England health reportingmedicine	STAT+: AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study - 2 months ago STAT+: Results on Novartis prostate cancer therapy could expand its use - about 1 year ago STAT+: Breast cancer drug from AstraZeneca, Daiichi hits goal in late-stage trial - about 1 year ago
5	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 2 months ago Embracing a Precision Medicine Approach to KRAS G12C–Mutated Advanced NSCLC With Adagrasib - 8 months ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Ahead of ASCO, J&J reports mixed data on next-generation radiopharmaceutical - 6 months ago
7	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novartis Pays $150M to Nab a Phase 3-Ready Protein Degrader for Prostate Cancer - 7 months ago
8	AFP Science Alert Science news. Official account. Australia science news	Scientists Predict Prostate Cancer Cases to Double Within 20 Years - 8 months ago
9	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Therapies - 10 months ago New Capivasertib Approval Benefits Patients With Breast Cancer, PIK3CA/AKT1/PTEN Alterations - 12 months ago FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Treatments - 12 months ago
10	Pharmaceutical Executive Editorial Staff Pharmaceutical Executive Pharma Executive Magazine. London & New Jersey PharmaceuticalsHealthcare	Zelix Pharmaceuticals Files BLA for PET Imaging Agent for Renal Cell Carcinoma - 11 months ago FDA Grants Fast Track, Breakthrough Designations to CG Oncology Inc’s Cretostimogene Grenadenorepvec - 11 months ago Xtandi Approved by FDA for Nonmetastatic Castration-Sensitive Prostate Cancer - about 1 year ago FDA Approves Truqap Plus Faslodex for Advanced HR-Positive Breast Cancer - about 1 year ago

Journalists covering castrate-resistant prostate cancer